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The central dogma of molecular biology describes the flow of genetic information from
DNA to protein via an RNA intermediate. For many years, RNA has been considered
simply as amessenger relaying information between DNA and proteins. Recent advances
in next generation sequencing technology, bioinformatics, and non-coding RNA biology
have highlighted the many important roles of RNA in virtually every biological process.
Our understanding of RNA biology has been further enriched by a number of significant
advances in probing RNA structures. It is now appreciated that many cellular and viral
biological processes are highly dependent on specific RNA structures and/or sequences,
and such reliance will undoubtedly impact on the evolution of both hosts and viruses. As
a contribution to this special issue on host immunity and virus evolution, it is timely to
consider how RNA sequences and structures could directly influence the co-evolution
between hosts and viruses. In this manuscript, we begin by stating some of the basic
principles of RNA structures, followed by describing some of the critical RNA structures
in both viruses and hosts. More importantly, we highlight a number of available new tools
to predict and to evaluate novel RNA structures, pointing out some of the limitations
readers should be aware of in their own analyses.
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INTRODUCTION
Mutation rates of viral genomes are extremely high when compared with those of eukaryotic cells;
RNA virus polymerases typically possess error rates of 10−4 to 10−6 per base (1). Such rapid
mutation is a strategy by which they can evade host adaptive immune responses (2). Antiviral
defenses of the innate immune system, which is less genetically flexible than the adaptive response,
enable a very broad range of recognition from which it is difficult for viruses to escape, even given
their high error rate. To counter the innate immune system, viruses have developed strategies to
block its activation. This arms race prompts the immune system to develop counter measures to
recognize and eliminate the virus, whilst viruses that survive and transmit successfully are those
that have evolved to escape it. When considering the evolutionary pressures on both virus and
host, research has often focused on the protein sequences needed by each. A recent explosion in
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our understanding of the functions of RNA, however, leads us to
consider instead the role of RNA itself in driving the evolution of
viruses and of human immunity.
RNA is a truly multifunctional molecule. It directs ribosomes
(themselves RNA based enzymes) to produce proteins, but
also regulates cellular activity by interacting directly with
proteins or nucleic acids and by catalyzing biochemical reactions
(ribozymes). Indeed, RNA is now implicated in almost every
cellular process, including immune defense. It is also recognized
as being key to viral infection processes. RNA multifunctionality
comes from its ability to fold into complex three-dimensional
structures that can often switch conformation to effect different
functions such as binding other RNA molecules or proteins.
The initial fold of an RNA molecule depends primarily
on its sequence and is established by Watson-Crick pairing
of complementary bases into stem-loop structures that then
orientate themselves relative to one another [for a general review
of RNA structure see (3)]. This three-dimensional positioning
can be stabilized by non-canonical interactions or structures
such as pseudoknots, which occur where the nucleotides of
a loop region base pair intramolecularly with complementary
nucleotides. An example is shown in Figure 1A, within the
complex structural element known as an IRES (internal ribosome
entry site). As for proteins, single nucleotide mutations can alter
the three-dimensional structure of the RNA, with corresponding
deleterious or positive effects on its function; RNA structures
are hence substrates for, and drivers of, viral evolution. For
example, randommutation may confer a new beneficial function
on a given structure that is then selectively favored by
evolution.
Viruses are known to be extremely thrifty with their
genomes to maximize replication speed, using strategies such as
overlapping reading frames and polycistronic mRNAs. Similarly,
they often contain functional RNA structures within both
coding and non-coding regions. For example, the first 500
nucleotides of the HIV-1 genome is densely packed with
structured domains that control key steps of the replication
cycle including transcription, translation, export, packaging,
and reverse transcription (7–9) and structural switches that
aid their regulation (5, 10–12). Functionality encoded within
an RNA structure is often a requisite for successful initiation
or completion of viral replication. Many viruses, particularly
those of the picornaviridae, initiate translation from IRES
elements (13). RNA structures facilitating frameshifting enable
viruses to encode multiple proteins from a single RNA (14).
Additionally, viral RNA structures may directly or indirectly
impact cellular immunity. In HIV-1, the transactivation response
element (TAR, Figure 1B) regulates transcription of the genomic
RNA and gene expression (15) thereby playing a central role
in determining the level of virus detected by the immune
system; at its most extreme leading to complete evasion of the
immune response through latency (16). Frameshift structures
or splicing regulators qualitatively and quantitatively manage
the amounts of proteins produced by viruses, and hence those
that are seen by the immune system (17). For example, some
strains of Influenza A virus encode a second open reading frame
(ORF) in segment three which is accessed by a low frequency
+1 ribosome frameshifting event (18). This ORF produces PA-
X, a protein which modulates inflammatory, apoptotic, and T-
lymphocyte signaling pathways (18). Viruses with larger genomes
can even produce their own microRNAs (19) or long non-
coding RNAs (lncRNAs) that control cellular functions (20, 21).
Dengue virus expresses a subgenomic RNA that has been shown
to inhibit interferon expression by binding to TRIM25 (22).
This subgenomic RNA is produced when a cellular 5′-to-3′
exoribonuclease stalls at a stable pseudoknot RNA structure in
the 3
′
UTR; small substitutions within this structure modulate
viral fitness and pathogenicity through their effects on the
immune system. The dengue 3’UTR also folds differently in
humans and insects (23) leading to production of different
immunomodulatory non-coding RNAs in each host type (22, 23).
This is one mechanism by which the same viral genome can both
effectively replicate in human and insect cells and counteract
these two divergent immune systems.
The immune system senses viral RNA using different
mechanisms, including the recognition of viral single-stranded
RNA by Toll-like receptors (24). The importance of RNA
structures in viral replication is so fundamental that they are
directly recognized by the innate immune response. Not only has
the innate immune system evolved to recognize double-stranded
RNA (dsRNA) within viral genomes or genomic replication
intermediates, often via MDA5, it has also evolved to recognize
the double-stranded parts of conserved RNA elements like
IRESs (13) or 3’ stem-loops, via RIG-I [reviewed in (25)]. The
importance of this in maintaining broad antiviral defense is
reflected in the fact that such RNA structures are also formed
by DNA viruses in their protein-coding RNAs. The cellular
double-stranded RNA recognition system not only leads to
production of interferon, but was recently shown to upregulate
NKG2D ligand, thus alerting NK cells to the presence of virus
and enabling destruction of the infected cell (26). Viruses have
evolved strategies to mask recognition of their RNAs, such as
5’ cap-snatching (27), but their need to maintain certain critical
RNA structures means that they struggle to avoid recognition
entirely.
VIRAL EVOLUTION TO EVADE AN IMMUNE
RESPONSE MAY BE CONSTRAINED OR
FACILITATED BY RNA STRUCTURE
The presence of essential conserved viral RNA structures can
constrain the ability of viruses to evolve and to evade the
immune response. Some RNA viruses have optimized their
genome structure and organization to facilitate viral evolution
during co-infection of the same cell with different viral strains.
One widespread strategy is genome segmentation leading
to reassortment (seen in rotaviruses and influenza viruses)
(28). Another common strategy is template switching during
replication leading to recombination and the formation of
genome chimeras (seen in retroviruses) (29). Reassortment and
recombination are non-random processes that are known to
depend on RNA sequence and structure, but the underlying
mechanisms are often poorly understood. Both processes may be
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FIGURE 1 | Examples of RNA structures. (A) Structural diagram of the hepatitis C virus IRES structure, showing its pseudoknot. Adapted from Malygin et al.(4), (B)
Structural model of the HIV-1 5’leader RNA, highlighting some of the important RNA structures it contains. Adapted from Kenyon et al. (5), (C) An RNA guanine
quadruplex structure, showing the 4-way bonds between guanines in each plane. Adapted from Frees et al. (6).
facilitated by inter-molecular interactions (30, 31), and evolution
can be both promoted or inhibited by intra-molecular RNA
structure.
In HIV-1, each virion contains two copies of the RNA genome,
which in the case of co-infection of the same cell can originate
from two different proviruses. These are non-covalently joined
as a dimer via stem-loop 1 (SL1, Figure 1B). During viral
replication, reverse transcriptase (RT) switches template, thereby
adding template switching generated errors to its inherently
low fidelity, producing the genetic diversity that allows HIV-
1 to rapidly escape the immune system and antiretroviral
therapy (2). Sequence incompatibility preventing formation of
heterodimers of genomic RNA at SL1 has been shown to be a
major restriction to inter-subtype recombination, with only a 3-
nt sequence difference being sufficient to disrupt this (32). When
considering distantly-related strains of HIV with compatible
SL1 sequences, the main factor governing recombination is the
degree of local sequence similarity (33, 34) However, in more
closely-related viral sequences, RNA structures strongly influence
recombination locally (35–37). This has been shown to be the
case for well-defined RNA structures within env such as the
C2 hairpin and the Rev responsive element (RRE) (38). It has
been suggested that this evolved to favor the stepwise folding
of proteins during translation, but it has also been shown to
favor the occurrence of recombination in these same regions (37).
As a consequence, recombination may shuﬄe whole domains of
proteins thus generating structural variants that escape immune
recognition, particularly for quaternary epitopes generated by
the juxtaposition of different protein domains. RNA structures
and sequences have also been shown to influence the fidelity
of reverse transcription such that stable secondary structures
enhance the number and type of mutations incorporated (39, 40).
The regions of env encoding the external parts of the viral
surface glycoprotein gp120 are under strong positive selection
by the humoral immune system. Perhaps counterintuitively they
present a lower degree of RNA structure; however, this can be
accounted for by such rapid viral mutation that the RNA is
unable to conserve base-pairing. As studies have shown, poorly
structured RNA regions are reverse transcribed with higher
fidelity, which paradoxically limits the rate of introduction of
mutations in these highly variable regions of the genome (39).
RNA viruses with segmented genomes can undergo
reassortment, leading to the exchange of entire gene segments,
potentially giving rise to new viral strains to which humans have
no previous immunity. In influenza A, reassortment has been
historically associated with the emergence of pandemic strains,
including the most recent H1N1 2009 pandemic which contained
influenza gene segments from human, avian and swine lineages
(41, 42). It is thought that packaging sequences within each gene
segment direct their selective incorporation into virus particles
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(43, 44) and recent work suggests a mechanism where packaging
signals mediate RNA-RNA interactions that would guide
their incorporation. It therefore follows that any preferential
interactions or incompatibilities between vRNP segments would
then regulate genetic reassortment and influenza evolution (45).
It is possible that improved understanding of this process would
help to better predict the emergence of pandemic influenza.
In addition to genome diversification through recombination
and reassortment, RNA structures influence immune escape
by modulating the viral proteome. The use of frameshifting
or alternative start codons is often controlled by viral RNA
structures, resulting in the translation of viral peptides or
proteins in a different reading frame. The resulting peptides
are often antigenic and may act to dilute the presentation of
conventional viral peptides on the surface of the infected cell (46).
In some viruses there is an evolutionary constraint to maintain
translation-impeding RNA structures in genes that encode good
T cell epitopes, thus maintaining their translation at levels too
low to trigger T cell recognition and killing. The EBNA-1 RNA
from Epstein-Barr virus for example regulates its own translation
in cis (47) and the evolutionary pressure on this gene comes from
the need to maintain G-quadruplex RNA structures (Figure 1C)
that act as “steric blocks” to ribosomes. When these structures
are destabilized, cells infected with the resulting mutant virus are
more readily seen by T cells than those infected with wild-type
virus (48).
Viruses also appear to be under pressure to maintain
unstructured regions in their genome: there is a bias in HIV-
1 toward the use of A’s in the retroviral genome; this biases
codon usage and ultimately even the amino acid composition
of the viral proteins (49). Adenosines are vastly overrepresented
in the single-stranded regions of RNA and underrepresented
in double-stranded regions; their only binding partner, U,
can also pair with G, which may explain the single-stranded
nature of A-rich regions. Artificial introduction of extensive
synonymous A to G mutations in pol led to increased stability
of the dimeric genome inside the virion, and reduced reverse
transcription as a result (50). The signature distribution of
Adenosine frequency and its relation to local RNA structure
was thought to be maintained by the influence of RNA
secondary structures on reverse transcription. Changing the
A ratio in local areas by only including codons found in
natural isolates of HIV-1, did not affect replication efficiency
in vitro (51) however it is possible that in vivo viruses use
this strategy of maintaining parts of their genome as single-
stranded in order to avoid innate immune recognition by
RIG-I or MDA5. Many viruses also need to maintain a low
number of CpG dinucleotides in their genome in order to
avoid recognition by the zinc-finger antiviral protein (ZAP)
(52). When HIV-1 codon usage was humanized, affecting the
native RNA structure, a reduced IFN-α/β response was observed
(53), suggesting that the maintenance of specific structures in
the viral genome comes at the cost of greater recognition by
the innate immune response. Despite this, the viral genome
apparently undergoes positive selection for the maintenance of
many specific RNA structures: when synonymous mutations
were introduced extensively into the viral genome a decrease
in infectivity was observed that could be attributed to an
expected alteration of splicing pattern and/or modification of
RNA structures (50, 54).
THE ROLES OF VIRAL AND CELLULAR
RNA STRUCTURE IN THE EVOLUTION OF
HUMAN IMMUNE RESPONSES AND THE
HUMAN IMMUNE SYSTEM
In terms of the evolution of the human genome, the degree
of variation at the MHC class I locus is positively correlated
with local pathogen richness, for which viruses are postulated
to play an important role. This is particularly evident for
HLA B (55). The importance of RNA structure in influencing
the generation of T cell epitopes, either through translational
enhancing, blocking, or frameshifting mechanisms, means that
RNA structures within viruses must have influenced the
evolution of the HLA locus. For example, macaques that have
the correct MHC-I allele to present an antigenic cryptic peptide
derived from the env ORF are better able to control simian
immunodeficiency virus (SIV) infection (56) which would be
expected to be a driver for the maintenance of this MHC allele
within the population. As mentioned above, the mechanisms
controlling the generation of cryptic translational products are
often RNA structure-dependent.
Viral RNA structures have also influenced the evolution of
the innate immune system; as previously discussed, hallmarks
of viral RNAs are targeted by conserved RNA-binding proteins
such as RIG-I. More specific antiviral proteins have also evolved,
however. APOBEC3 proteins target retroviral genomes and are
incorporated into viral particles (57). These host cell-derived
cytidine deaminases bind to the viral RNA and mutate it during
the reverse transcription process, leading to non-functional virus.
It has been reported that regions of the genome under strong
purifying selection present an underrepresentation of APOBEC3
target sequences, a signature of a strong pressure for limiting the
occurrence of mutations in certain regions of the genome (39).
Retroviruses have also developed direct strategies to counteract
these proteins, often by encoding proteins that bind to them
directly. Interestingly, APOBEC3s have recently been shown
to bind to the same motifs in the viral RNA genome as the
viral NC structural protein involved in genome packaging. This
suggests a competitive relationship may have developed between
host cell and viral factors, for binding to the same viral RNA
structures (58).
NOVEL WAYS TO EXPLORE RNA
STRUCTURE AND FUNCTION
RNA functionality is best understood through its structure, but
RNA structure determination is extremely challenging. Although
it is formed based on simple base pairing rules, for RNA
molecules of biologically relevant sizes there are an astronomical
number of possible structural permutations, meaning that RNA
structure cannot be predicted easily from base pairing rules alone.
Biophysical methods such as crystallography (59) and NMR (60)
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are each able to determine RNA structure at atomic resolution but
both have difficulty with large RNA substrates. This is evidenced
by the paucity of atomic resolution RNA structures, compared
to their protein equivalents. For example, the RCSB databank
holds structural data for over 100,000 proteins, but contains only
around 1000 RNA structures. This difficulty arises because RNA
molecules tend to adopt long flexible shapes with weak tertiary
interactions that are prone to misfolding (61). Furthermore,
the negatively charged phosphate groups on the surface of an
RNA molecule can impose technical challenges as they hinder
crystal packing. Newer techniques are emerging to address this
gap including small-angle X-ray scattering (62), single molecule
FRET (63, 64), and atomic force microscopy (65).
RNA secondary structure is currently most commonly
resolved using a combination of (i) phylogenetic approaches
(ii), structure prediction algorithms, and (iii) experimental
methods with chemical/enzymatic probes. Whilst these
methodologies cannot determine RNA structure at atomic
resolution, they are nevertheless able to generate models that
provide useful biological insights (8, 66, 67). Indeed, RNA
structure determination is currently undergoing a revolution
thanks to advances in next generation sequencing technology
that have transformed traditional biochemical assays into
powerful tools that can characterize thousands of RNA
structures in single experiments (68–71). The most widely used
methods take advantage of chemical probes, such as dimethyl
sulfate (DMS) and selective 2′-hydroxyl acylation analyzed by
primer extension (SHAPE) reagents, that differentially react
with single stranded vs double stranded RNA. Knowledge of
whether a nucleotide is likely to be base paired or not can
significantly improve the accuracy of RNA structure predictions
from thermodynamic folding algorithms when included as an
energetic consideration in the modeling programme, known as
a pseudo free energy parameter (72). For example, if chemical
probes show a nucleotide is single-stranded, the modeling
algorithm adds an energetic penalty to structures that include
it in a double-stranded region. The programme then displays
the most energetically favorable structures, that fit all of the data
best. Several chemical probes can penetrate cells and virions,
which is important for understanding RNA function in vivo,
such as the binding sites of regulatory proteins (9, 73). Further
characterization of RNA structure-function relationships can
be obtained using specialized approaches, such as mutational
interference mapping experiment (MIME) (74) and cross-linking
SHAPE (XL-SHAPE), where protein binding sites are mapped
using UV cross-linking in parallel with SHAPE probing (75), and
by CLIP (crosslinking-immunoprecipitation sequencing) related
methodologies (76). More recently, RNA proximity ligation has
emerged as a new class of RNA structural probing technique for
the direct detection of long-range base pairing or inter-molecular
interactions (77–84). These types of interactions are commonly
found in viral genomes/regulatory RNAs and are difficult to
identify with other methodologies. As the immune system is
known to be regulated by non-coding RNAs (85), the ability to
detect direct interactions between viral and cellular RNAs will
be particularly important for future understanding of virus-host
interactions.
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